Calf blood deproteinized extract for injection

Pharmacological action: This product can enhance the uptake and utilization of oxygen and glucose by tissue cells and improve the cellular hypoxic state.

A sterile freeze-dried product containing inorganic and small molecular organic substances obtained by deproteinization, concentration, ultrafiltration or dialysis of fresh calf blood or serum

This product is off-white or light yellow mass or amorphous powder, easily soluble in water.

1. Various diseases that cause brain hypoxia, such as cerebral hemorrhage, cerebral embolism, encephalitis, cerebral arteriosclerosis, Alzheimer's disease, and resuscitation. 2. Acute and chronic hepatitis, symptomatic hepatitis, and liver cirrhosis. 3. Improve the quality of life of tumor patients and reduce the side effects of radiotherapy and chemotherapy. 4. Used as an energy mixture to treat myocarditis, coronary heart disease, etc. 5. Peptic ulcer, atrophic gastritis.

Intravenous drip. Stroke and brain trauma: 0.8-1.2g total solid amount (4-6 bottles) dissolved in 250ml 5% glucose injection or 0.9% sodium chloride injection, slowly dripped intravenously (drip rate less than 2ml/min) once a day, two weeks as a course of treatment.

Occasionally, there may be reactions such as fever, rash, and hypotension.

1. It is contraindicated for patients with severe renal dysfunction. 2. It is contraindicated for patients with allergic reactions to similar drugs.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Not yet clear.

Protect from light and moisture

400mg(total solid)

18 months

Harbin Shengtai Biopharmaceutical Co., Ltd.

• Founded in:

  2011-08-29

• Address:

  Shenyang Street, Limin Economic and Technological Development Zone, Harbin, Heilongjiang Province

• Tax NO.:

  912301115780742259

• Registered Funds:

  100 million yuan

• Website:

  Log in to view

• Email:

  Log in to view